IP Library › Granted Patent US 10,265,030
Granted Patent B2
US 10,265,030 · App. 14/973,403 · Granted Apr 23, 2019

Receivers for analyzing and displaying sensor data

Inventors: Eric Johnson (San Marcos, CA); Michael Robert Mensinger (San Diego, CA); Peter C. Simpson (Cardiff, CA); Thomas Hall (San Diego, CA); Hari Hampapuram (Carlsbad, CA); Kostyantyn Snisarenko (San Diego, CA); Eli Reihman (San Diego, CA); Holly Chico (San Diego, CA); Kassandra Constantine (San Diego, CA)
Assignee: DexCom, Inc.
A61B5/7425A61B5/0004A61B5/0013A61B5/1495A61B5/14532A61B5/742A61B5/743A61B5/746A61B5/7445A61B5/7475G01N33/66G06F3/041G06F3/0488G06F3/04847G06F3/04883G06F3/04886G06F19/00G06F19/3468G06T3/00G06T11/20G16H40/63H04N21/431
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,265,030
App. No.
14/973,403
Granted
Apr 23, 2019
Kind
B2
Abstract

This disclosure provides systems, methods and apparatus for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor. The system may include a display device with at least one input device. In response to movement of or along the input device, the display device may change a glucose data output parameter and update an output of the display device using the changed output parameter.

Claims (27)

1. A method for displaying analyte concentration data on a computing device, comprising:

receiving analyte concentration data from a sensor;

calculating a clinical value of the analyte concentration data;

activating a display of the computing device in a lock state;

displaying a first indication of the calculated clinical value on the display while the computing device is in the lock state, wherein the first indication is associated with a glucose monitoring application comprising a first glucose chart displaying a graphical representation of the analyte concentration data;

adjusting the first indication by detecting a touchscreen gesture on the display of the computing device while the computing device is in the lock state; and

displaying a second indication of the calculated clinical value without launching the glucose monitoring application, the second indication including a second glucose chart, the second glucose chart displaying a portion of the graphical representation of the first glucose chart.

2. The method of claim 1 , wherein the analyte concentration data is glucose concentration data.

3. The method of claim 1 , wherein the indication is the clinical glucose value.

4. The method of claim 3 , wherein the clinical glucose value is displayed as an icon, and wherein a color of the icon, or a color of the background, is based on the clinical glucose value or on the trend or both.

5. The method of claim 1 , wherein the indication is a trend indicator.

6. The method of claim 5 , wherein the trend indicator is a trend graph or a trend arrow.

7. The method of claim 5 , wherein the trend indicator is displayed on a background of the computing device.

8. The method of claim 5 , wherein the trend indicator is displayed as an icon.

9. The method of claim 8 , wherein a color of the icon is based on the clinical value or on the trend or both.

10. The method of claim 1 , wherein the indication is a color.

11. The method of claim 10 , wherein the color is selected from green, yellow, or red, according to increasing levels of urgency associated with the clinical value.

12. The method of claim 11 , wherein the color is green if the user is in euglycemia and a trend indicator indicates the user will not become hypoglycemic or hyperglycemic.

13. The method of claim 11 , wherein the color is yellow if the user is in euglycemia and a trend indicator indicates the user will become hypoglycemic or hyperglycemic.

14. The method of claim 11 , wherein the color is yellow if the user is in hypoglycemia or hyperglycemia and a trend indicator indicates the user is trending towards euglycemia.

15. The method of claim 11 , wherein the color is red if the user is in hypoglycemia or hyperglycemia and a trend indicator indicates the user is trending away from euglycemia.

16. The method of claim 1 , wherein the indication allows the user to observe glucose information without displaying a main user interface of the glucose monitoring application.

17. The method of claim 1 , wherein the indication allows the user to observe glucose information by activating a maximum of one button.

18. The method of claim 1 , wherein the indication is activated by a signal received from an accelerometer in the computing device.

19. The method of claim 1 , wherein the indication allows the user to observe glucose information without requiring additional display area.

20. The method of claim 1 , wherein tapping the indication opens a main user interface of the continuous glucose monitoring application.

21. The method of claim 1 , wherein the indication is displayed as an icon and includes the clinical value, and wherein the clinical value has a font or font formatting based on the clinical glucose value or on a trend of the clinical glucose value.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2016
From: JOHNSON, ERIC; MENSINGER, MICHAEL ROBERT; SIMPSON, PETER C.; HALL, THOMAS; HAMPAPURAM, HARI; SNISARENKO, KOSTYANTYN; REIHMAN, ELI; CHICO, HOLLY; CONSTANTINE, KASSANDRA
To: DEXCOM, INC.
Reel/Frame 037777/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2016
From: JOHNSON, ERIC; MENSINGER, MICHAEL ROBERT; SIMPSON, PETER C.; HALL, THOMAS; HAMPAPURAM, HARI; SNISARENKO, KOSTYANTYN; REIHMAN, ELI; CHICO, HOLLY; CONSTANTINE, KASSANDRA
To: DEXCOM, INC.
Reel/Frame 037780/0586 →
Continuity (4)
Continuation 14098383 · Dec 5, 2013
Continuation 13026163 · Feb 11, 2011
Provisional Application 61304337 · Feb 12, 2010
Related Publication 20160100807A1 · Apr 14, 2016
Cited By (4)
US 12,361,821 US 12,569,172 US 12,642,464 US 12,653,426